Kaye, S.B., Lubinski, J., Matulonis, U., Ang, J.E., Gourley, C., Karlan, B.Y., et al. (2012) Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly(ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients with BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 30, 372-379.
Related Articles:
Efficacy and Safety of PDM011011 Capsules as Compared to Metformin in Subjects with Type-2 Diabetes Mellitus: An Open-Label, Randomized, Active-Controlled, Multicentric, Phase III Study
Ashish C. Suthar, Vikas G. Pai, Yogesh Kadam, Aniruddha Tongaonkar, Shailaja Kale, Atul B. Deshpande, Sharat Kolke, Snehal Tanna, Shrikant V. Deshpande, Purvi Chawla, Debjit Biswas, Somesh Sharma
DOI:
10.4236/jdm.2016.61005
5,397 Downloads 6,522 Views Citations
Pub. Date:
February
4,
2016
Efficacy and Safety of Tinefcon® Tablets in Subjects with Plaque Psoriasis: An Open Label, Non-Comparative, Multicenter, Phase IV Trial
Somesh Sharma, Kailash Bhatia, Meetesh Agarwal, Sandesh Gupta, Leelavathi Budamakuntla, Sudhakar Grandhi, Vinod Titarmare, Sushil Pande, Ranjan Rawal, Aruna Samarth, Rizwan Haq, Vikrant Saoji, D. V. S. Pratap, L. M. Kansal, D. G. Saple, Shatrughan Sahay, Parag Kalyani, Puneet Goyal, Sharmila Patil, A. J. Kanwar, Bhavesh Swarnakar, Abhijeet Morde, Hitesh Khandagale, Yogesh Dound, Nitin Jadhav, Sanjeev Hegde, Murlidhara Padigaru, Ashish C. Suthar, Sujay Kulkarni
DOI:
10.4236/jcdsa.2016.62008
3,080 Downloads 4,168 Views Citations
Pub. Date:
April
25,
2016
